# A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse Methylprednisolone in Early Rheumatoid Arthritis: A Magnetic Resonance Imaging Study

> **NCT00396747** · PHASE4 · COMPLETED · sponsor: **Université Catholique de Louvain** · enrollment: 45 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Infliximab, methylprednisolone, methotrexate
- **DRUG:** Methotrexate
- **DRUG:** Methotrexate + Methylprednisolone
- **DRUG:** Methotrexate + Infliximab

## Key facts

- **NCT ID:** NCT00396747
- **Lead sponsor:** Université Catholique de Louvain
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** —
- **Final completion:** 2005-09
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2007-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00396747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00396747, "A Comparison of Methotrexate Alone or Combined to Infliximab or to Pulse Methylprednisolone in Early Rheumatoid Arthritis: A Magnetic Resonance Imaging Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00396747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*